Inspira Technologies Oxy B.H.N. Ltd. (IINN)
NASDAQ: IINN · IEX Real-Time Price · USD
1.210
-0.060 (-4.72%)
At close: Jul 19, 2024, 4:00 PM
1.100
-0.110 (-9.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure.
Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels.
The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N.
Ltd. in July 2020. Inspira Technologies Oxy B.H.N.
Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Inspira Technologies Oxy B.H.N. Ltd.
Country | Israel |
Founded | 2018 |
IPO Date | Jul 14, 2021 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 42 |
CEO | Dagi Shahar Ben-Noon |
Contact Details
Address: Hatidhar 2, 11th Floor Ra'anana, L3 4366504 Israel | |
Phone | 972-9-9664488 |
Website | inspira-technologies.com |
Stock Details
Ticker Symbol | IINN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $5.51 |
CIK Code | 0001837493 |
CUSIP Number | M53637100 |
ISIN Number | IL0011715781 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer and Director |
Joe Hayon | Co-Founder, President and Director |
Yafit Tehila | Chief Financial Officer |
Avi Shabtai | Chief Operating Officer and Vice President of Research and Development |
Daniella Yeheskely-Hayon Ph.D. | Chief Technology Officer |
Meshira Greenberg | Administrative Manager |
Adi Shmueli | Marketing and Communications Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 11, 2024 | 6-K | Report of foreign issuer |
Jun 20, 2024 | 6-K | Report of foreign issuer |
Jun 18, 2024 | 6-K/A | Filing |
Jun 18, 2024 | 424B5 | Filing |
Jun 17, 2024 | 6-K | Report of foreign issuer |
Jun 13, 2024 | 6-K | Report of foreign issuer |
Jun 11, 2024 | 144 | Filing |
May 28, 2024 | 6-K | Report of foreign issuer |
May 23, 2024 | EFFECT | Notice of Effectiveness |
May 20, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |